Double mutation of APC and BRCA1 in an Italian family-Reference-Cited by-同舟云学术

Double mutation of APC and BRCA1 in an Italian family

Published:2020-06 Issue: Volume:244 Page:32-35
ISSN:2210-7762
Container-title:Cancer Genetics
language:en
Short-container-title:Cancer Genetics

Author:

Vietri Maria Teresa,D'Elia Giovanna,Caliendo Gemma,Casamassimi Amelia,Resse Marianna,Passariello Luana,Cioffi Michele,Molinari Anna Maria

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Molecular Biology

Reference21 articles.

1. Hereditary diffuse gastric cancer and lynch syndromes in a BRCA1/2 negative breast cancer patient;Njoroge;Breast Cancer Res Treat,2017

2. Novel mutations and phenotypic associations identified through APC, MUTYH, NTHL1, POLD1, POLE gene analysis in Indian Familial Adenomatous Polyposis cohort;Khan;Sci Rep,2017

3. Familial Adenomatous polyposis syndrome: an update and review of extraintestinal manifestations;Dinarvand;Arch Pathol Lab Med,2019

4. A novel frameshift mutation in exon 12 of the adenomatous polyposis coli gene in an Italian family with familial adenomatous polyposis and desmoid tumour;Vietri;J Mol Genet Med,2010

5. Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas;Grover;JAMA,2012

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hereditary Cancer Syndrome in a Family with Double Mutation in BRIP1 and MUTYH Genes;Genes;2023-02-08

2. The expression and mutation of BRCA1/2 genes in ovarian cancer: a global systematic study;Expert Review of Molecular Diagnostics;2023-01-02

3. APCgermline pathogenic variants and epithelial ovarian cancer: causal or coincidental findings?;Journal of Medical Genetics;2022-10-21

4. Increased Risk of Hereditary Prostate Cancer in Italian Families with Hereditary Breast and Ovarian Cancer Syndrome Harboring Mutations in BRCA and in Other Susceptibility Genes;Genes;2022-09-21

5. Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients;BMC Cancer;2022-08-02